Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 299

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1

Open access
Freedman, Barry I., Langefeld, Carl D., Andringa, Kelly K., Croker, Jennifer A., Williams, Adrienne H., Garner, Neva E., Birmingham, Daniel J., Hebert, Lee A., Hicks, Pamela J., Segal, Mark S., Edberg, Jeffrey C., Brown, Elizabeth E., Alarcón, Graciela S., Costenbader, Karen H., Comeau, Mary E., Criswell, Lindsey A., Harley, John B., James, Judith A., Kamen, Diane L., Lim, S. Sam, Merrill, Joan T., Sivils, Kathy L., Niewold, Timothy B., Patel, Neha M., Petri, Michelle, Ramsey‐Goldman, Rosalind, Reveille, John D., Salmon, Jane E., Tsao, Betty P., Gibson, Keisha L., Byers, Joyce R., Vinnikova, Anna K., Lea, Janice P., Julian, Bruce A., Kimberly, Robert P., on behalf of the Lupus Nephritis–End‐Stage Renal Disease Consortium·2014·Arthritis & Rheumatology

Abstract

Objective: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) that exhibits familial aggregation and may progress to end‐stage renal disease (ESRD). LN is more prevalent among African Americans than among European Americans. This study was undertaken to investigate the hypothesis that the apolipoprotein L1 gene (APOL1) nephropathy risk alleles G1/G2, common in African Americans and rare in European Americans, contribute to the ethnic disparity in risk. Methods: APOL1 G1 and G2 nephropathy alleles were genotyped in 855 African American SLE patients with LN‐ESRD (cases) and 534 African American SLE patients without nephropathy (controls) and tested for association under a recessive genetic model, by logistic regression. Results: Ninety percent of the SLE patients were female. The mean ± SD age at SLE diagnosis was significantly lower in LN‐ESRD cases than in SLE non‐nephropathy controls (27.3 ± 10.9 years versus 39.5 ± 12.2 years). The mean ± SD time from SLE diagnosis to development of LN‐ESRD in cases was 7.3 ± 7.2 years. The G1/G2 risk alleles were strongly associated with SLE‐ESRD, with 25% of cases and 12% of controls having 2 nephropathy alleles (odds ratio [OR] 2.57, recessive model P = 1.49 × 10−9), and after adjustment for age, sex, and ancestry admixture (OR 2.72, P = 6.23 × 10−6). The age‐, sex‐, and admixture‐adjusted population attributable risk for ESRD among patients with G1/G2 polymorphisms was 0.26, compared to 0.003 among European American patients. The mean time from SLE diagnosis to ESRD development was ∼2 years earlier among individuals with APOL1 risk genotypes (P = 0.01). Conclusion: APOL1 G1/G2 alleles strongly impact the risk of LN‐ESRD in African Americans, as well as the time to progression to ESRD. The high frequency of these alleles in African Americans with near absence in European Americans explains an important proportion of the increased risk of LN‐ESRD in African Americans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.38220

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 299

Metadata

Authors
Freedman, B. I., Langefeld, C. D., Andringa, K. K., Croker, J. A., Williams, A. H., Garner, N. E., Birmingham, D. J., Hebert, L. A., Hicks, P. J., Segal, M. S., Edberg, J. C., Brown, E. E., Alarcón, G. S., Costenbader, K. H., Comeau, M. E., Criswell, L. A., Harley, J. B., James, J. A., Kamen, D. L., Lim, S. S., Merrill, J. T., Sivils, K. L., Niewold, T. B., Patel, N. M., Petri, M., Ramsey‐Goldman, R., Reveille, J. D., Salmon, J. E., Tsao, B. P., Gibson, K. L., Byers, J. R., Vinnikova, A. K., Lea, J. P., Julian, B. A., Kimberly, R. P., & on behalf of the Lupus Nephritis–End‐Stage Renal Disease Consortium
Venue
Arthritis & Rheumatology
Publisher
Wiley
Published
2014-01-27
Volume
66
Issue
2
Pages
390-396
ISSN
  • 2326-5191 (ISSN-L)
  • 2326-5205
OpenAlex
W1765667024
Cited by
299
References
29
FWCI
18.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1. https://app.cochat.ai/papers/10.1002/art.38220
The paper
Freedman, B. I., Langefeld, C. D., Andringa, K. K., Croker, J. A., Williams, A. H., Garner, N. E., Birmingham, D. J., Hebert, L. A., Hicks, P. J., Segal, M. S., Edberg, J. C., Brown, E. E., Alarcón, G. S., Costenbader, K. H., Comeau, M. E., Criswell, L. A., Harley, J. B., James, J. A., Kamen, D. L., . . . on behalf of the Lupus Nephritis–End‐Stage Renal Disease Consortium. (2014). End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1. Arthritis & Rheumatology. https://doi.org/10.1002/art.38220

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.